Endocrine Abstracts

Introduction: Sarcopenic obesity (SO), characterized by the coexistence of obesity and sarcopenia, is a condition increasingly recognized for its clinical and functional features, which impairs patients’ quality of life and increases the risk of morbidity and mortality. In order to improve the management of obese patients, we aimed to screen for sarcopenia in obese adults and to identify the nutritional risk factors associated with sarcopenic obesity.<p class="abstext...

Introduction: Loss of skeletal muscle mass and function, which defines sarcopenia, generally occurs with ageing, and is commonly associated with relative or absolute fat mass gain; this process contributes to the potential development of sarcopenic obesity. However, sarcopenia can occur in people suffering from obesity at any age. We aimed therefore to screen for sarcopenia in a group of obese adults, and to identify the biological risk factors associated with sarcopenic obesi...

Introduction : Sarcopenia is a clinical condition defined as low skeletal muscle mass and function. It has been identified and described as a geriatric syndrome, increasing the risk of frailty, comorbidities and mortality. However, sarcopenia may arise in individuals with obesity at any age. Our objective was therefore to screen for sarcopenia in a group of obese adults.Materials and methods: This was a descriptive cross-sectional study, carried out on 5...

Introduction: Sarcopenia, defined as the loss of skeletal muscle mass and function, is common for individuals with obesity due to adipose tissue disorders, metabolic changes associated with a sedentary lifestyle and during the ageing process. However, sarcopenia can occur in obese people at any age. Our objectives were therefore to screen for sarcopenia in a group of obese adults, and to identify the clinical risk factors associated with sarcopenic obesity.<p class="abstex...